On­col­o­gy re­search mid-pan­dem­ic: Chal­lenges may bring durable in­no­va­tion

Though clin­i­cal re­search, in gen­er­al, has been chal­lenged dur­ing the COVID-19 pan­dem­ic, on­col­o­gy tri­als “have sev­er­al unique con­sid­er­a­tions due to dis­ease sever­i­ty, reg­i­men com­plex­i­ty, and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.